Clinical Trial Update: A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pembrolizumab in combination with radiation therapy for malignant pleural mesothelioma; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Pleural Mesothelioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING